1. Home
  2. TVTX vs LOPE Comparison

TVTX vs LOPE Comparison

Compare TVTX & LOPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$42.68

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

LOPE

Grand Canyon Education Inc.

HOLD

Current Price

$160.72

Market Cap

4.5B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TVTX
LOPE
Founded
N/A
1949
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.5B
IPO Year
2013
2008

Fundamental Metrics

Financial Performance
Metric
TVTX
LOPE
Price
$42.68
$160.72
Analyst Decision
Strong Buy
Buy
Analyst Count
13
2
Target Price
$40.62
$220.00
AVG Volume (30 Days)
2.7M
219.9K
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
92.89
N/A
EPS
N/A
2.80
Revenue
N/A
$511,257,000.00
Revenue This Year
$44.76
$8.67
Revenue Next Year
$35.51
$6.66
P/E Ratio
N/A
$57.48
Revenue Growth
N/A
N/A
52 Week Low
$13.88
$149.37
52 Week High
$48.61
$223.04

Technical Indicators

Market Signals
Indicator
TVTX
LOPE
Relative Strength Index (RSI) 62.11 39.54
Support Level $26.97 $161.48
Resistance Level $48.61 $172.89
Average True Range (ATR) 2.21 6.07
MACD -0.28 -0.81
Stochastic Oscillator 36.23 11.74

Price Performance

Historical Comparison
TVTX
LOPE

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

About LOPE Grand Canyon Education Inc.

Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges, both online and on the ground at its campus in Phoenix, Arizona, and at four off-site classroom andlaboratory sites. The Company generates all of its revenue through service agreements with its university partners.

Share on Social Networks: